Protective Effects of Cell-Free Supernatants from a Kefir-Derived Microbial Consortium against Multidrug-Resistant Candida glabrata Associated with Vulvovaginal Candidiasis

Clicks: 21
ID: 320477
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #77 of 159 articles by views in medical mycology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 159 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Vulvovaginal candidiasis (VVC) caused by non-albicans Candida species, particularly Candida glabrata, is increasingly associated with treatment failure due to intrinsic or acquired resistance to antifungal drugs. In this study, we explored the anticandidal activity of a postbiotic cell-free supernatant (CFS) obtained from a microbial consortium isolated from homemade kefir (Lactococcus lactis subsp. hordniae, Lactococcus lactis subsp. lactis, and Pichia kudriavzevii) against one reference strain and two multidrug-resistant clinical isolates of C. glabrata. Antifungal susceptibility assays showed a fungistatic effect of CFS (MIC ≥ 500 µg/mL). Pre-treatment with sub-MIC concentrations (100 µg/mL) of CFS significantly reduced C. glabrata planktonic growth, and cell surface hydrophobicity, as well as A-431 vaginal epithelial cell damage. Although total biofilm biomass of C. glabrata was not markedly affected by pre-treatment, metabolic activity was significantly decreased, together with downregulation of key virulence genes (ALS3, ERG11, and FKS1). Subsequently, we explored the effect of the CFS on the inhibition and eradication of biofilms derived from pretreated cells, showing a more marked effect compared to biofilms from untreated cells. Furthermore, in pre-treated fungal cells the CFS almost completely abolished invasive capacity, reducing invasion in epithelial cells model and restored wound healing capacity following infection. Additionally, CFS modulated the host inflammatory response by reducing the expression of pro-inflammatory cytokines in A-431 cells. Overall, the kefir-derived postbiotic attenuated major virulence traits of C. glabrata and promote epithelial protection, providing preliminary evidence supporting its potential as a complementary approach for VVC prevention and management.
Reference Key
openalex_W7167952075 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Angela Maione, Marianna Imparato, Lea Di Massa, Annalisa Buonanno, Luigi Cirillo, Marco Guida, Elisabetta de Alteriis, Emilia Galdiero
Journal medical mycology
Year 2026
DOI
10.1093/mmy/myag073
URL
https://doi.org/10.1093/mmy/myag073
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.